Fintech PR
C.P. Group and Toyota/Commercial Japan Partnership Technologies achieved new milestones towards decarbonization with multi-faceted solutions across energy, data and mobility
- A joint partnership by Charoen Pokphand Group (C.P. Group), Toyota Motor Corporation (TMC) and Commercial Japan Partnership Technologies (CJPT) announced the successful pilot project for biogas-derived hydrogen production in Thailand.
- C.P. Group plans to use such biogas-derived hydrogen for their truck fleet for long-haul logistics for its supply chains, further accelerating Thailand’s decarbonization process.
- Successful test of new drone technology designed for agriculture use at scale
- Adoption of smart logistics and date to drive efficiencies in fleet management
DUBAI, UAE, Dec. 8, 2023 /PRNewswire/ — During the COP28 UN Climate Change Conference hosted in Dubai, UAE, Charoen Pokphand Group Co., Ltd. (C.P. Group), along with Toyota Motor Corporation (Toyota), and Commercial Japan Partnership Technologies (CJPT) announced progress in their pilot project to produce one of Thailand’s first bio-hydrogen supply of an initial volume of 2kg/day. The Thai-Japanese partnership announced that they have completed their first trial of using poultry waste to produce bio-hydrogen, marking an important milestone in their journey towards decarbonizing the transportation sector.
Backed by state-of-the-art equipment, biogas derived from poultry waste provided by C.P. Group’s farms is used to produce the bio-hydrogen. This collaborative effort demonstrates C.P. Group and Toyota/CJPT’s commitment to innovation and dedication to reducing greenhouse gas emissions. As part of this initiative, Toyota has also established Thailand’s first Biogas-Derived Hydrogen Production Equipment at its Asia headquarters in Samut Prakan province, south of Bangkok.
To showcase the potential of bio-hydrogen as a clean energy source, the team will now embark on its next phase to trial the fuel for long-haul transportation. This trial will test the viability and performance of bio-hydrogen as an alternative energy source for the transportation sector. Together, the companies hope to eventually adopt bio-hydrogen for C.P. Group’s long-haul logistics, including the powering of delivery trucks for parts of its operations in Thailand.
Speaking at the Thailand Pavilion at the COP28 UN Climate Change Conference in Dubai, C.P. Group Chairman Soopakij Chearavanont shared, “We are all in a race against climate change. COP28 presents a great opportunity for us all to come together, share ideas, and find innovative solutions. It is a privilege to unite with Toyota and Commercial Japan Partnership Technologies Corporation to find revolutionary renewable energy solutions and pioneering approaches. Together, we aspire to create a world where sustainability becomes a way of life.”
Bio-hydrogen has the potential to play a significant role in Thailand’s decarbonization journey, and in addition to poultry waste to biogas, the partnership is also exploring broader mobility solutions, and is pleased to announce the successful completion of a second test project into the role that drones can play in supporting agriculture in Thailand. Toyota created a fuel cell powered drone that has successfully been used across a number of CP farms in support of seeding, the fertilization of crops as well as other agricultural tasks.
Masahiko Maeda, CEO of Asia Region of Toyota Motor Corporation noted, “I am excited to see actual implementation progress with C.P. Group. We are achieving good results for CO2 reduction and considering how we can contribute further to the happiness of the 67 million Thai citizens under the concept of ‘doing what can be done now’, together with partners who share the same view. With the country’s agriculture resources combined with the extensive and strong value chain of C.P. Group along with Toyota/CJPT’s mobility business expertise, Thailand’s first trial for producing hydrogen from poultry farm’s biogas can be utilized for greener logistics. We would like to expand the scope of our collaboration to promote initiatives for carbon neutrality suited to Thailand in the three areas of energy, data and mobility.”
C.P. Group, through its subsidiaries, operates a large fleet of commercial vehicles. The partnership is actively exploring how different types of electric vehicles, including HEVs (hybrid electric), BEVs (battery electric) and FCEVs (fuel cell electric), can be optimized for both urban logistics and agricultural transportation, as well as how data can be effectively used to optimize loading processes and route planning to minimize fuel consumption and emissions associated with transportation.
C.P. Group Member of Executive Committee, Kachorn Chiaravanont said, “C.P. Group and Toyota have shared a common interest since the start of our relationship 25 years ago to support decarbonisation. We are excited about investing in new technologies and are ambitious in our combined ambition to find new ways to support the energy transition, for Thailand. Our aim is to explore the potential of producing, transporting and using bio-gas hydrogen across C.P. Group’s business, starting with trials in some of Thailand’s special economic zones and then deploying at scale in due time. We invite more partners and communities to join us in our mission and journey.”
By combining their expertise and resources, Charoen Pokphand Group, Toyota Motor Corporation, and Commercial Japan Partnership Technologies are committed to driving positive change and contributing to a more sustainable future.
About C.P. Group
For over a century, Charoen Pokphand Group (or C.P. Group) has strived to provide quality products and services to serve rising demand throughout the world. C.P. Group’s strong commitment to the ‘3-Benefit’ principle has contributed towards the organization’s sustainable growth with the aim to benefit the country and its people wherever it invests. Currently, the Group’s core businesses cover the agri-food, retail, and telecommunications industries with operations in 21 countries and employs more than 450,000 people worldwide. C.P. Group is recognized as a major contributor in the development of the Thai economy and society as well as those of all countries it operates in.
Toyota Motor Corporation
Toyota Motor Corporation works to develop and manufacture innovative, safe and high-quality products and services that create happiness by providing mobility for all. We believe that true achievement comes from supporting our customers, partners, employees, and the communities in which we operate. Since our founding over 80 years ago in 1937, we have applied our Guiding Principles in pursuit of a safer, greener and more inclusive society. Today, as we transform into a mobility company developing connected, automated, shared and electrified technologies, we also remain true to our Guiding Principles and many of the United Nations’ Sustainable Development Goals to help realize an ever-better world, where everyone is free to move.
SDGs Initiatives https://global.toyota/en/sustainability/sdgs/
Commercial Japan Partnership Technologies (CJPT)
In April 2021, Isuzu Motors Limited, Hino Motors, Ltd., and Toyota Motor Corporation established Commercial Japan Partnership Technologies (CJPT), a new company, with the aim to accelerate the implementation and spread of CASE in society to help address various difficulties facing the transportation industry as well as help achieve a carbon-neutral society. Suzuki Motor Corporation and Daihatsu Motor Co., Ltd. joined the partnership in July 2021. Among the many lessons at real logistics sites since CJPT was established, there has been a renewed awareness of both the magnitude of the challenges facing the transportation industry, such as the social cost of carbon neutrality and increased burden on workers and drivers, as well as the importance of working together with society to address these issues. Together with its partners, CJPT will accelerate its efforts with a focus on logistics efficiency and electrification.
Photo – https://mma.prnewswire.com/media/2296348/DSC05632.jpg
View original content:
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News7 days ago
“Grand Huangshan” Debuts at the 2024 World Brand Moganshan Conference
-
Latest News6 days ago
AI-powered Panax raises $15m to reshape cash flow management
-
Latest News7 days ago
Yili’s 2023 Revenue Reaches 126.2 Billion Yuan, Leading Global Dairy Industry towards Healthy and Sustainable Development
-
Latest News7 days ago
Egypt’s Swypex launches an all-in-one fintech platform after $4m seed round
-
Latest News7 days ago
Sweden’s Mitigram names Pedram Tadayon as new CEO
-
Latest News6 days ago
Sobha Developers bring to Singapore an Exclusive Dubai Property Showcase
-
Latest News6 days ago
South African fintech Lesaka snaps up Adumo in $86m deal
-
Latest News7 days ago
Venom and KuCoin Ventures forge strategic partnership